<div id="readability-page-1"><div> <div> Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. , /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Kezar Life Sciences, Inc. (NASDAQ: KZR)'s sale to Aurinia Pharmaceuticals Inc. for $6.955 in cash per share and one non-transferable contingent value right. If you are a Kezar shareholder, click here to learn more about your legal rights and options. Equitable Holdings, Inc. (NYSE: EQH)'s merger with Corebridge Financial, Inc. whereby each outstanding share of Equitable common stock will be exchanged for 1.55516 shares of the combined company's common stock. Upon closing of the proposed transaction, Equitable shareholders will own approximately 49% of the combined company. If you are an Equitable shareholder, click here to learn more about your legal rights and options. Urgent.ly, Inc. (OTC MarketsOTCQB: ULYX)'s sale to Agero, Inc. for $5.50 per share. If you are an Urgent.ly shareholder, click here to learn more about your rights and options. On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. One World Trade Center 85th Floor New York, NY 10007 (212) 763-0060 [email protected] [email protected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDE0Jk5ld3NJdGVtSWQ9TlkzNDE2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MTQxNjEzUFJfTkVXU19VU1BSX19fX19OWTM0MTY0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDE0Jk5ld3NJdGVtSWQ9TlkzNDE2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MTQxNjEzUFJfTkVXU19VU1BSX19fX19OWTM0MTY0"/></div> </div></div>

CRBG

AUPH

AKRO

ULYX

Halper Sadeh LLC is investigating Kezar Life Sciences, Equitable Holdings, and Urgent.ly for potential violations of federal securities laws and breaches of fiduciary duties. The firm is concerned that insiders may benefit financially at the expense of ordinary shareholders. They are encouraging shareholders to discuss their rights and options regarding the proposed transactions, which include KZR's sale to Aurinia Pharmaceuticals, EQH's merger with Corebridge Financial, and ULYX's sale to Agero. Halper Sadeh LLC offers legal assistance on a contingent fee basis.

16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?